FC
CYTK icon

FORA Capital’s Cytokinetics CYTK Stock Holding History

FORA Capital’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,503
Closed -$238K – 429
2024
Q3 		$238K Buy
+4,503
New +$251K 0.03% 382
2024
Q2 		– Sell
-82,776
Closed -$5.8M – 405
2024
Q1 		$5.8M Buy
82,776
+73,128
+758% +$5.66M 0.48% 67
2023
Q4 		$806K Buy
+9,648
New +$349K 0.07% 272
2020
Q4 		– Sell
-1,907
Closed -$41K – 959
2020
Q3 		$41K Buy
+1,907
New +$44.6K 0.03% 469

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

FORA Capital's CYTK Position: Q4 2024 in Review

FORA Capital sold out of Cytokinetics (CYTK) in Q4 2024, closing a stake of 4,503 shares — an estimated $238K sold.

FORA Capital first reported a position in CYTK in Q3 2020 and held it in 4 quarters. The position peaked at $5.8M in Q1 2024. 346 funds tracked by Wall St. Rank hold CYTK as of Q4 2024.

  • FORA Capital reported no remaining Cytokinetics position as of Q4 2024 after selling out during the quarter.
  • FORA Capital sold 4,503 Cytokinetics shares in Q4 2024, an estimated $238K.
  • FORA Capital first reported a position in Cytokinetics in Q3 2020 and held it in 4 quarters.
  • FORA Capital's Cytokinetics position peaked at $5.8M in Q1 2024.
  • 346 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2024.

Based on FORA Capital's 13F filing for Q4 2024, filed 14 Feb 2025.